CPC-113 Preoperative Oral Iron Prescription in the Prevention of Postoperative Acute Anaemia in Orthopaedic Surgery
Background A previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always treated. We have recommended prescribing oral iron in the month preceding surgery. A pre-dispensed oral iron prescription has been set up for...
Saved in:
Published in | European journal of hospital pharmacy. Science and practice Vol. 20; no. Suppl 1; p. A205 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.03.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background A previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always treated. We have recommended prescribing oral iron in the month preceding surgery. A pre-dispensed oral iron prescription has been set up for use during preoperative anaesthesia consultations. We decided to evaluate the impact of this recommendation by a second study in 2012 (S2). Purpose To assess the impact of preoperative oral iron prescription on the prevalence and treatment of postoperative acute anaemia in orthopaedic surgery. Materials and Methods Both studies included patients who underwent total hip or knee arthroplasty (THA/TKA). S1 was conducted retrospectively on all patients operated on in 2011. S2 was conducted prospectively on patients who had been prescribed preoperative iron in September/October 2012. We collected data about operations, iron prescriptions, haemoglobin levels, transfusions and lengths of stay. ResultsOperations: 327 (S1): 205THA/122TKA vs. 30 (S2): 13THA/17TKA. Postoperative iron prescription: 69% of patients (S1): oral iron 32%, intravenous iron 20%, both oral and intravenous iron 17% vs. 43% of patients (S2): oral iron 23%, intravenous iron 13%, both oral and intravenous iron 7%. Haemoglobin levels: between preoperative and immediate postoperative periods, mean decrease was from 12.9 ± 0.2 g/dl to 11.1 ± 0.1 g/dl (S1) vs. 13.3 ± 0.2 g/dl to 11.7 ± 0.2 g/dl (S2), between preoperative period and hospital discharge, mean loss was 2.2 ± 0.2 g/dl (S1) vs. 1.9 ± 0.17 g/dl (S2) (p < 10–3). Transfusions: 29% of patients (S1) vs. 20% (S2) (p < 10–3). Length of stay: mean was 10.6 ± 0.8 days (S1) vs. 8.3 ± 0.3 days (S2) (p < 0.005). Conclusions The prospective study showed that oral iron preventive treatment significantly decreases haemoglobin level fall, transfusion rate and length of stay. Therefore it is necessary to sensitise prescribers concerning preventive iron coverage. A further study is needed to evaluate the impact of a longer iron preventive treatment on a larger number of patients. No conflict of interest. |
---|---|
AbstractList | Background A previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always treated. We have recommended prescribing oral iron in the month preceding surgery. A pre-dispensed oral iron prescription has been set up for use during preoperative anaesthesia consultations. We decided to evaluate the impact of this recommendation by a second study in 2012 (S2). Purpose To assess the impact of preoperative oral iron prescription on the prevalence and treatment of postoperative acute anaemia in orthopaedic surgery. Materials and Methods Both studies included patients who underwent total hip or knee arthroplasty (THA/TKA). S1 was conducted retrospectively on all patients operated on in 2011. S2 was conducted prospectively on patients who had been prescribed preoperative iron in September/October 2012. We collected data about operations, iron prescriptions, haemoglobin levels, transfusions and lengths of stay. Results Operations: 327 (S1): 205THA/122TKA vs. 30 (S2): 13THA/17TKA. Postoperative iron prescription: 69% of patients (S1): oral iron 32%, intravenous iron 20%, both oral and intravenous iron 17% vs. 43% of patients (S2): oral iron 23%, intravenous iron 13%, both oral and intravenous iron 7%. Haemoglobin levels: between preoperative and immediate postoperative periods, mean decrease was from 12.9 ± 0.2 g/dl to 11.1 ± 0.1 g/dl (S1) vs. 13.3 ± 0.2 g/dl to 11.7 ± 0.2 g/dl (S2), between preoperative period and hospital discharge, mean loss was 2.2 ± 0.2 g/dl (S1) vs. 1.9 ± 0.17 g/dl (S2) (p < 10-3). Transfusions: 29% of patients (S1) vs. 20% (S2) (p < 10-3). Length of stay: mean was 10.6 ± 0.8 days (S1) vs. 8.3 ± 0.3 days (S2) (p < 0.005). Conclusions The prospective study showed that oral iron preventive treatment significantly decreases haemoglobin level fall, transfusion rate and length of stay. Therefore it is necessary to sensitise prescribers concerning preventive iron coverage. A further study is needed to evaluate the impact of a longer iron preventive treatment on a larger number of patients. No conflict of interest. Background A previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always treated. We have recommended prescribing oral iron in the month preceding surgery. A pre-dispensed oral iron prescription has been set up for use during preoperative anaesthesia consultations. We decided to evaluate the impact of this recommendation by a second study in 2012 (S2). Purpose To assess the impact of preoperative oral iron prescription on the prevalence and treatment of postoperative acute anaemia in orthopaedic surgery. Materials and Methods Both studies included patients who underwent total hip or knee arthroplasty (THA/TKA). S1 was conducted retrospectively on all patients operated on in 2011. S2 was conducted prospectively on patients who had been prescribed preoperative iron in September/October 2012. We collected data about operations, iron prescriptions, haemoglobin levels, transfusions and lengths of stay. ResultsOperations: 327 (S1): 205THA/122TKA vs. 30 (S2): 13THA/17TKA. Postoperative iron prescription: 69% of patients (S1): oral iron 32%, intravenous iron 20%, both oral and intravenous iron 17% vs. 43% of patients (S2): oral iron 23%, intravenous iron 13%, both oral and intravenous iron 7%. Haemoglobin levels: between preoperative and immediate postoperative periods, mean decrease was from 12.9 ± 0.2 g/dl to 11.1 ± 0.1 g/dl (S1) vs. 13.3 ± 0.2 g/dl to 11.7 ± 0.2 g/dl (S2), between preoperative period and hospital discharge, mean loss was 2.2 ± 0.2 g/dl (S1) vs. 1.9 ± 0.17 g/dl (S2) (p < 10–3). Transfusions: 29% of patients (S1) vs. 20% (S2) (p < 10–3). Length of stay: mean was 10.6 ± 0.8 days (S1) vs. 8.3 ± 0.3 days (S2) (p < 0.005). Conclusions The prospective study showed that oral iron preventive treatment significantly decreases haemoglobin level fall, transfusion rate and length of stay. Therefore it is necessary to sensitise prescribers concerning preventive iron coverage. A further study is needed to evaluate the impact of a longer iron preventive treatment on a larger number of patients. No conflict of interest. BackgroundA previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always treated. We have recommended prescribing oral iron in the month preceding surgery. A pre-dispensed oral iron prescription has been set up for use during preoperative anaesthesia consultations. We decided to evaluate the impact of this recommendation by a second study in 2012 (S2).Purpose To assess the impact of preoperative oral iron prescription on the prevalence and treatment of postoperative acute anaemia in orthopaedic surgery.Materials and Methods Both studies included patients who underwent total hip or knee arthroplasty (THA/TKA). S1 was conducted retrospectively on all patients operated on in 2011. S2 was conducted prospectively on patients who had been prescribed preoperative iron in September/October 2012. We collected data about operations, iron prescriptions, haemoglobin levels, transfusions and lengths of stay.ResultsOperations: 327 (S1): 205THA/122TKA vs. 30 (S2): 13THA/17TKA. Postoperative iron prescription: 69% of patients (S1): oral iron 32%, intravenous iron 20%, both oral and intravenous iron 17% vs. 43% of patients (S2): oral iron 23%, intravenous iron 13%, both oral and intravenous iron 7%. Haemoglobin levels: between preoperative and immediate postoperative periods, mean decrease was from 12.9 ± 0.2 g/dl to 11.1 ± 0.1 g/dl (S1) vs. 13.3 ± 0.2 g/dl to 11.7 ± 0.2 g/dl (S2), between preoperative period and hospital discharge, mean loss was 2.2 ± 0.2 g/dl (S1) vs. 1.9 ± 0.17 g/dl (S2) (p < 10–3). Transfusions: 29% of patients (S1) vs. 20% (S2) (p < 10–3). Length of stay: mean was 10.6 ± 0.8 days (S1) vs. 8.3 ± 0.3 days (S2) (p < 0.005).ConclusionsThe prospective study showed that oral iron preventive treatment significantly decreases haemoglobin level fall, transfusion rate and length of stay. Therefore it is necessary to sensitise prescribers concerning preventive iron coverage. A further study is needed to evaluate the impact of a longer iron preventive treatment on a larger number of patients.No conflict of interest. |
Author | Dupont, X Benhamou, F Boyeldieu, D Le Mercier, F Chauny, JV Politis, B Razurel, A Hardy, P |
Author_xml | – sequence: 1 givenname: A surname: Razurel fullname: Razurel, A organization: Hospital Ambroise Paré, Pharmacy, Boulogne Billancourt, France – sequence: 2 givenname: JV surname: Chauny fullname: Chauny, JV organization: Hospital Ambroise Paré, Pharmacy, Boulogne Billancourt, France – sequence: 3 givenname: B surname: Politis fullname: Politis, B organization: Hospital Ambroise Paré, Pharmacy, Boulogne Billancourt, France – sequence: 4 givenname: X surname: Dupont fullname: Dupont, X organization: Hospital Ambroise Paré, Anaesthesia, Boulogne Billancourt, France – sequence: 5 givenname: D surname: Boyeldieu fullname: Boyeldieu, D organization: Hospital Ambroise Paré, Blood products, Boulogne Billancourt, France – sequence: 6 givenname: F surname: Benhamou fullname: Benhamou, F organization: Hospital Ambroise Paré, Orthopaedic surgery, Boulogne Billancourt, France – sequence: 7 givenname: F surname: Le Mercier fullname: Le Mercier, F organization: Hospital Ambroise Paré, Pharmacy, Boulogne Billancourt, France – sequence: 8 givenname: P surname: Hardy fullname: Hardy, P organization: Hospital Ambroise Paré, Orthopaedic surgery, Boulogne Billancourt, France |
BookMark | eNqNkclOwzAURS0EEqX0HyKxTvHseFlVDJUqtRKwtpzEJqmaODhJpe7Y8KN8CQ5h2CE2Hq7ueW9xLsBp7WoDQITgHCHCr82uaArtqxhDRGIIIRZ8zgQ8ARMMqYil5PT05834OZi1bZlCRkgiKZET0C-3yzjMen9923rjGuN1Vx5MtPF6H628q6MQt5kvm64Mn7KOusIM2cHUn4mz0da13S-5yPounLU2VakHYOO7wjXa5GUWPfT-2fjjJTizet-a2dc9BU-3N4_L-3i9uVstF-s4RVLC2FqkOTWWI8hoklhODOE5w5IJSpMUUiRwKhGxOcIJ0RTaPEs045DJFLFUkym4Guc23r30pu3UzvW-DisVZgwLJgSkf7WQSCiSEDMRWsnYyrxrW2-sanxZaX9UCKrBhvq2oQYbarShgo2AkhFNq93_qQ8lFJF2 |
ContentType | Journal Article |
Copyright | 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
Copyright_xml | – notice: 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: 2013 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
DBID | AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. PQEST PQQKQ PQUKI PRINS |
DOI | 10.1136/ejhpharm-2013-000276.570 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Databases BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest One Academic Eastern Edition ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2047-9964 |
EndPage | A205 |
ExternalDocumentID | 4035020631 10_1136_ejhpharm_2013_000276_570 |
GroupedDBID | 0R~ 3V. 53G 7X7 8FI 8FJ AAYAA ABKRM ABUWG ABVAJ ABWEH ADBBV ADMRH AFKRA AHMBA AHQMW AJYBZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BTHHO C45 CCPQU CXRWF EBS EJD FYUFA H13 HAJ HMCUK HYE OK1 OVD PQQKQ PROAC RHI RMJ RPM TEORI UKHRP AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-b1990-ff1a64ef6105488f63e36d52957448b04172b913fd1283a40fdc8a56059b15ba3 |
IEDL.DBID | BENPR |
ISSN | 2047-9956 |
IngestDate | Thu Oct 10 15:58:56 EDT 2024 Thu Oct 10 18:37:50 EDT 2024 Fri Aug 23 00:57:26 EDT 2024 Wed Aug 21 03:28:43 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1990-ff1a64ef6105488f63e36d52957448b04172b913fd1283a40fdc8a56059b15ba3 |
OpenAccessLink | https://ejhp.bmj.com/content/ejhpharm/20/Suppl_1/A205.2.full.pdf |
PQID | 1784190257 |
PQPubID | 2040966 |
ParticipantIDs | proquest_journals_2552757704 proquest_journals_1784190257 crossref_primary_10_1136_ejhpharm_2013_000276_570 bmj_primary_10_1136_ejhpharm_2013_000276_570 |
PublicationCentury | 2000 |
PublicationDate | 20130300 2013-03-00 20130301 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 20130300 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | European journal of hospital pharmacy. Science and practice |
PublicationYear | 2013 |
Publisher | BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group LTD |
SSID | ssib053389439 ssj0000605265 ssib018287486 |
Score | 1.9002376 |
Snippet | Background A previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always... BackgroundA previous study on postoperative acute anaemia in orthopaedic surgery was conducted in 2011 (S1), showing that anaemia is recurrent and not always... |
SourceID | proquest crossref bmj |
SourceType | Aggregation Database Publisher |
StartPage | A205 |
SubjectTerms | Anemia Hemoglobin Iron Length of stay Orthopedics Surgery |
Title | CPC-113 Preoperative Oral Iron Prescription in the Prevention of Postoperative Acute Anaemia in Orthopaedic Surgery |
URI | http://dx.doi.org/10.1136/ejhpharm-2013-000276.570 https://www.proquest.com/docview/1784190257 https://www.proquest.com/docview/2552757704 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF5se_EiioqPWnLw6Npsd7NJTlJLRQVrUQu9hd1kFxWaxLS9e_GP-kucaRKLIIKXBJIMgS-TeezMfkPIqcvDQMQsoQa8KRWxUlQJw6hhoafB_YEQ7ne-G8nribidetNqwW1etVXWNnFlqJMsxjXybg-pwjzfd8VF_kZxahRWV6sRGg3S6jGBZdrW5XA0fqg1iq3o3NcEaRDbIN94-L0K40rkO8E-xx5SFuA2z7rdh8uueX3OkUAaVAlnIGAKJ889nGvc0LPXn57spyFfeaerbbJVhZVOv9SDHbJh0l2yHIwHFF7x-f4xLkyWm5Ll27kv4NGbIksdbMCozYbzkjoQDTo1qRNcyayDw3zXkv14uYBjqszsRaHAfbF4hrQbqz3OY7nDeo9MroZPg2tajVmgmoEvotYyJYWxEEhB-hJYyQ2XCRYAfcjdtCsgxtEh4zYBX8aVcG0SBwoiJS_UzNOK75NmmqXmAICzIK50IgOtheFg1AMVSjhZnNNu40NyBsBFeUmkEa0SEC6jGucIcY5KnCPA-ZCwGuF_yLTrTxFVv-M8YlhdxYKq_-vttW4d_X37mGyWqoA9aG3SXBRLcwJByUJ3SMOf-p1K_74Ay6vdBQ |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,33777,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF60HvQiior1mYNHV7PuZpOcpBSlPltQobdlN9mlFUxqbO9e_KP-EmfysAgieEkgyRD4MpnHzuw3hBz5PI5EwlJqwZtSkWhNtbCMWhYHBtwfCOF-57t72XsS18NgWC-4vdVtlY1NLA11mie4Rn56hlRhQRj64nzySnFqFFZX6xEai2RJcC5Qz8PhtztlJZn7nB4NIhtkG4-_12B8iWwn2OV4hoQFuMmzafbh8tQ-jyZIHw2KhBMQMIGTJwFONV40L88__dhPM176pss1sloHlV6n0oJ1smCzDTLrDroUXvH5_jEobD6xFce31y_g0asizzxsv2iMhjfOPIgFvYbSCa7kzsNRvnPJTjKbwjHT9mWsUaBfTEeQdGOtx3uo9ldvkqfLi8duj9ZDFqhh4Imoc0xLYR2EUZC8RE5yy2WK5b8QMjfjC4hwTMy4S8GTcS18lyaRhjgpiA0LjOZbpJXlmd0G4ByIa5PKyBhhOZj0SMcSTg6ntLukTY4BODWpaDRUmX5wqRqcFeKsKpwV4NwmrEH4HzJ7zadQ9c_4phjWVrGcGv56e65ZO3_fPiTLvce7W3V7dX-zS1YqtcButD3SmhYzuw_hydQclDr4BVBZ3aU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA6ugngRRcW3PXg0bmPStD2JrC6ur13Qhb2FpE1QwXatu3cv_lF_iTN9uAgieGmh7VCYTueRmXwfIYc-jyORsJRaiKZUJFpTLSyjlsWBgfAHQrjf-fZOXg7F1SgY1fNPb_VYZeMTS0ed5gmukbdPECosCENftF09FjE4756OXykySGGntabTaJEFiJI-0jiEo-_Qykpg9xlUGmQ5iDwef6_H-BKRT3Di8QTBC3DDZzP4w2XbPj-OEUoajArZELCYk8cBMhy3zMvzz5j206WXcaq7QpbrBNM7qyxilczZbI1MO4MOhVd8vn8MCpuPbYX37fULeLRX5JmHoxiNA_GeMg_yQq-Bd4IrufOQ1ncmeZZMJ3DMtH150ijQLyaPUIBj38e7r_Zar5Nh9-Khc0lrwgVqGEQl6hzTUlgHKRUUMpGT3HKZYiswhCrO-AKyHRMz7lKIalwL36VJpCFnCmLDAqP5BpnP8sxuguIciGuTysgYYTm490jHEk4OGdtdskWOQHFqXEFqqLIU4VI1elaoZ1XpWYGetwhrNPwPmd3mU6j6x3xTDPus2FoNf709s7Ltv28fkEUwP3XTu7veIUuVVeBg2i6ZnxRTuweZysTslyb4BdJO4dE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CPC-113%E2%80%85Preoperative+Oral+Iron+Prescription+in+the+Prevention+of+Postoperative+Acute+Anaemia+in+Orthopaedic+Surgery&rft.jtitle=European+journal+of+hospital+pharmacy.+Science+and+practice&rft.au=Razurel%2C+A&rft.au=Chauny%2C+JV&rft.au=Politis%2C+B&rft.au=Dupont%2C+X&rft.date=2013-03-01&rft.issn=2047-9956&rft.eissn=2047-9964&rft.volume=20&rft.issue=Suppl+1&rft.spage=A205&rft.epage=A205&rft_id=info:doi/10.1136%2Fejhpharm-2013-000276.570&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_ejhpharm_2013_000276_570 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9956&client=summon |